BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 22241371)

  • 21. Dramatic response to chloroquine and mirtazapine for recalcitrant atopic dermatitis.
    Zirwas MJ
    Dermatitis; 2006 Dec; 17(4):208-10. PubMed ID: 17150173
    [No Abstract]   [Full Text] [Related]  

  • 22. Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.
    Sudo K; Yamaguchi T; Ishihara T; Nakamura K; Shirai Y; Nakagawa A; Kawakami H; Uno T; Ito H; Saisho H
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):219-24. PubMed ID: 17189072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Corneal epithelial disorder, lacrimal drainage obstruction, and conjunctivitis].
    Kase S
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():490-3. PubMed ID: 25831809
    [No Abstract]   [Full Text] [Related]  

  • 24. Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer.
    Kinoshita T; Nashimoto A; Yamamura Y; Okamura T; Sasako M; Sakamoto J; Kojima H; Hiratsuka M; Arai K; Sairenji M; Fukushima N; Kimura H; Nakajima T
    Gastric Cancer; 2004; 7(2):104-9. PubMed ID: 15224197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mirtazapine for treatment of nausea induced by selective serotonin reuptake inhibitors.
    Caldis EV; Gair RD
    Can J Psychiatry; 2004 Oct; 49(10):707. PubMed ID: 15560319
    [No Abstract]   [Full Text] [Related]  

  • 26. [An early phase II clinical study of S-1 in patients with breast cancer. S-1 Cooperative Study Group (Breast Cancer Working Group)].
    Taguchi T; Morimoto K; Horikoshi N; Takashima S; Toge T; Kimura M; Sano M; Aoyama H; Ota J; Noguchi S
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1035-43. PubMed ID: 9644319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer chemotherapy and cachexia: mirtazapine and olanzapine are 5-HT3 antagonists with good antinausea effects.
    Kast RE; Foley KF
    Eur J Cancer Care (Engl); 2007 Jul; 16(4):351-4. PubMed ID: 17587360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Examination of s-1 therapy for adjuvant chemotherapy in patients with advanced gastric cancer].
    Matsui K; Nashimoto A; Yabusaki H; Nakagawa S; Nomura T; Takii Y; Tsuchiya Y; Tanaka O
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):953-7. PubMed ID: 19542714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of S-1 for stage IV gastric cancer].
    Kanazawa Y; Furukawa K; Yamada T; Shirakawa T; Fujita I; Kato S; Yokoi K; Uchida E
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1619-22. PubMed ID: 21996955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case report of complete response to low-dose S-1 monotherapy for pancreatic cancer in elderly patient].
    Sato R; Kawamura M; Kawamura T; Sasaki K; Ushigome T; Nyumura Y
    Gan To Kagaku Ryoho; 2012 Dec; 39(13):2569-71. PubMed ID: 23235182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial.
    Zhu X; Ju X; Cao F; Fang F; Qing S; Shen Y; Jia Z; Cao Y; Zhang H
    BMJ Open; 2016 Dec; 6(12):e013220. PubMed ID: 27909037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient chemotherapy with S-1 for recurrent head and neck cancer.
    Yamashita T; Shinden S; Watabe T; Shiotani A
    Anticancer Res; 2009 Feb; 29(2):577-81. PubMed ID: 19331206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1143-5. PubMed ID: 16632163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alternate-day oral therapy with S-1 for adjuvant chemotherapy of gastric cancer].
    Takebayashi K; Kawai Y; Tagi T; Matsumura M; Shimizu K; Yamamoto H; Mekata E; Tani T; Sato M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):385-7. PubMed ID: 22421764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of drug-induced pulmonary injury showing organizing pneumonia pattern due to S-1].
    Nakata H; Shinano H; Kuraya D; Fujioka Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):955-7. PubMed ID: 22705691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.
    Koizumi W; Narahara H; Hara T; Takagane A; Akiya T; Takagi M; Miyashita K; Nishizaki T; Kobayashi O; Takiyama W; Toh Y; Nagaie T; Takagi S; Yamamura Y; Yanaoka K; Orita H; Takeuchi M
    Lancet Oncol; 2008 Mar; 9(3):215-21. PubMed ID: 18282805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case of liver metastasis of gastric cancer responding well to TS-1].
    Niinobu T; Yamamoto M; Taniguchi M; Kotobuki T; Otsuka A
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1674-7. PubMed ID: 15553680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of S-1 monotherapy as a first-line treatment for elderly patients with advanced nonsmall-cell lung cancer: the Central Japan Lung Study Group trial 0404.
    Nishiyama O; Taniguchi H; Kondoh Y; Takada K; Baba K; Saito H; Sugino Y; Yamamoto M; Ogasawara T; Kondo M; Imaizumi K; Hasegawa Y; Suzuki R; Shimokata K;
    Anticancer Drugs; 2011 Sep; 22(8):811-6. PubMed ID: 21317767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report.
    Sueda T; Kudo T; Sakai D; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Ezoe S; Matsumoto K; Doki Y; Mori M; Satoh T
    Cancer Chemother Pharmacol; 2014 Dec; 74(6):1321-4. PubMed ID: 25374410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of postoperative radiotherapy concurrent with S-1 in patients with gastric cancer.
    Qiu M; Peng XC; Bi F; Wang X; Li Q; Xu F; Li ZP; Shen YL; Liu JY; Zhao YQ; Cao D; Gou HF; Yang Y; Chen Y; Yi C
    Med Oncol; 2015 Jul; 32(7):191. PubMed ID: 26025485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.